When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?

Recommendations have been issued for vaccinating with the Sanofi Pasteur tetravalent dengue vaccine (CYD-TDV, Dengvaxia(®)) individuals aged from 9 to 45/60 years old with a prior dengue virus (DENV) infection and living in endemic countries/areas. One question linked to these recommendations is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guy, Bruno, Ooi, Eng Eong, Ramos-Castañeda, Jose, Thomas, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349415/
https://www.ncbi.nlm.nih.gov/pubmed/32283639
http://dx.doi.org/10.3390/vaccines8020174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349415/
https://www.ncbi.nlm.nih.gov/pubmed/32283639
http://dx.doi.org/10.3390/vaccines8020174

Ejemplares similares